Kirby has served in a wide array of Senior and Executive health care leadership positions within managed care, specialty pharmacy, health care consulting, health care technology, provider network development, group purchasing, specialty distribution and pharmaceutical manufacturing. Prior to OutcomeRx, Kirby’s key roles and responsibilities include oncology and specialty drug management solutions, business development, strategic planning, and sales and marketing representing organizations that include D2 Solutions, Onco360, CVS Health, CuraScript/ExpressScript, US Oncology, Oncology Therapeutics Network, Sicor, Fujisawa and Eli Lilly & Company.
As Chief Clinical Officer for OutcomeRx, Kirby is responsible for creating and implementing practical patient centered cell and gene therapy clinical solutions that align key stakeholders with cost-effective options that complement OutcomeRx’s reinsurance and therapy warranty solutions. Kirby also oversees the development of personalized patient support services that address the clinical and financial complexities for patients receiving cell and gene-based therapies and addressing the unique needs of associated caregivers. Kirby is a licensed pharmacist with a B.S. in Pharmacy from the Arnold & Marie Schwartz College of Pharmacy and is an active member of the American Society of Gene & Cell Therapy, National Association of Specialty Pharmacy, and the Academy of Managed Care Pharmacy. Kirby has also been published in a wide variety of professional publications including the Journal of NCCN, Specialty Pharmacy Times, Drug Topics and the Journal of Managed Care.
